Transdermal scopolamine for the prevention of postoperative nausea and vomiting: A systematic review and meta-analysis

Clinical Therapeutics

Volumn 32, Issue 12, 2010, Pages 1987-2002

  Apfel, Christian C ^a   Zhang, Kun ^a,b   George, Elizabeth ^a,c   Shi, Serena ^a,d   Jalota, Leena ^a   Hornuss, Cyrill ^a   Fero, Katherine E ^a   Heidrich, Felix ^a,b   Pergolizzi, Joseph V ^e,f   Cakmakkaya, Ozlem S ^g   Kranke, Peter ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ISTANBUL UNIVERSITY   (Turkey)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Antiemetic; Meta analysis; PONV; Postoperative nausea; Postoperative vomiting; Prophylaxis; Systematic review; Transdermal scopolamine patch

Indexed keywords

PLACEBO; SCOPOLAMINE;

CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; HUMAN; META ANALYSIS; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; SKIN IRRITATION; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINE RETENTION; VISUAL DISORDER; XEROSTOMIA;

ADMINISTRATION, CUTANEOUS; ANTIEMETICS; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; SCOPOLAMINE;

EID: 78649597734     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.11.014     Document Type: Review

References (68)

1. Kovac AL Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000, 59:213-243.
2. Watcha MF, White PF Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992, 77:162-184.
3. Cullen KA, Hall MJ, Golosinskiy A Ambulatory surgery in the United States, 2006. Natl Health Stat Report 2009, 1-25.
4. Clissold SP, Heel RC Transdermal hyoscine (scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985, 29:189-207.
5. Kranke P, Morin AM, Roewer N, et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analg. 2002, 95:133-143.
6. Higgins JP, Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 2009, Wiley-Blackwell, Hoboken, NJ.
7. Transderm Scop [package Insert] 2006, Novartis Consumer Health, Inc, Parsippany, NJ.
8. Bradford TH, Robertson K, Norman PF, Meeks GR Reduction of pain and nausea after laparoscopic sterilization with bupivacaine, metoclopramide, scopolamine, ketorolac, and gastric suctioning. Obstet Gynecol. 1995, 85(5 Pt 1):687-691.
9. Clarke RS, Dundee JW, Carson IW, et al. Clinical studies of induction agents. XL. Althesin with various premedicants. Br J Anaesth. 1972, 44:845-848.
10. Clarke RS, Dundee JW, Love WJ Studies of drugs given before anaesthesia. 8. Morphine 10 mg alone and with atropine or hyoscine. Br J Anaesth. 1965, 37:772-778.
11. Davies DR, Doughty A Premedication of children with papaveretumhyoscine. The effect ofvarying dosage schemes. Br J Anaesth. 1967, 39:638-644.
12. Davies DR, Doughty AG Premedication in children. A trial of intramuscular droperidol, droperidolphenoperidine, papaveretum-hyoscine and normal saline. Br J Anaesth. 1971, 43:65-75.
13. Guldbrand P, Mellström A Rectal versus intramuscular morphinescopolamine as premedication in children. Acta Anaesthesiol Scand. 1995, 39:224-227.
14. Kamath B, Curran J, Hawkey C, et al. Anaesthesia, movement and emesis. Br J Anaesth. 1990, 64:728-730.
15. Larsson S, Hägerdal M, Lundberg D Premedication with intramuscular dixyrazine: (Esucos). A controlled double-blind comparison with morphine-scopolamine and placebo. Acta Anaesthesiol Scand. 1988, 32:131-134.
16. Lundgren S Comparison of rectal diazepam and subcutaneous morphinescopolamine administration for out-patient sedation in minor oral surgery. Acta Anaesthesiol Scand. 1985, 29:674-678.
17. Michaloudis D, O'Keeffe N, O'Sullivan K, Healy TE Postoperative nausea and vomiting: A comparison of antiemetic drugs used alone or in combination. J R SocMed. 1993, 86:137-138.
18. Moscovici R, Prego G, Schwartz M, Steinfeld O Epidural scopolamine administration in preventing nausea after epidural morphine. J Clin Anesth. 1995, 7:474-476.
19. Paymaster NJ Evaluation of anxiolytic and amnesic effects of intramuscular lorazepam as a pre-operative medication. Curr Med Res Opin. 1976, 4:388-394.
20. Raeder JC, Breivik H Premedication with midazolam in out-patient general anaesthesia. A comparison with morphine-scopolamine and placebo. Acta Anaesthesiol Scand. 1987, 31:509-514.
21. Raeder JC, van der Linden J, Breivik H Premedication for day-case surgery: Double-blind comparison of ketobemidone + dimethylaminodiphenylbuten (A-29) and morphine + scopolamine. Acta Anaesthesiol Scand. 1986, 30:502-506.
22. Sear JW, Alexander JI Comparison of buprenorphine-hyoscine and papaveretum-hyoscine as premedicants for gynaecological surgery. Br J Anaesth. 1983, 55:319-324.
23. Simpson KH, Dearden MJ, Ellis FR, Jack TM Premedication with slow release morphine (MST) and adjuvants. BrJ Anaesth. 1988, 60:825-830.
24. Tarkkila P, Törn K, Tuominen M, Lindgren L Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine. Acta Anaesthesiol Scand. 1995, 39:983-986.
25. Harris SN, Sevarino FB, Sinatra RS, et al. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia. Obstet Gynecol. 1991, 78:673-677.
26. Schuh R, Tolksdorf W, Hucke H Transdermal scopolamine or droperidol in the prevention of postoperative nausea and vomiting in cholecystectomy patients [in German]. Anasth Intensivther Notfallmed. 1987, 22:261-266.
27. Thune A, Appelgren L, Haglind E Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine. Eur J Surg. 1995, 161:265-268.
28. White PF, Tang J, Song D, et al. Transdermal scopolamine: An alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms. Anesth Analg. 2007, 104:92-96.
29. Doyle E, Byers G, McNicol LR, Morton NS Prevention of postoperative nausea and vomiting with transdermal hyoscine in children using patient-controlled analgesia. Br J Anaesth. 1994, 72:72-76.
30. Honkavaara P, Saarnivaara L, Klemola UM Effect of transdermal hyoscine on nausea and vomiting after surgical correction of prominent ears under general anaesthesia. Br J Anaesth. 1995, 74:647-650.
31. Horimoto Y, Naide M Transdermal scopolamine patches reduce postoperative emesis in pediatric patients undergoing strabismus surgery. Can J Anaesth. 1990, 37(4 Pt 2):S94.
32. Horimoto Y, Tomie H, Hanzawa K, Nishida Y Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery. Can J Anaesth. 1991, 38(4 Pt 1):441-444.
33. Honkavaara P, Pyykkö I Surgeon's experience as a factor for emetic sequelae after middle ear surgery. Acta Anaesthesiol Scand. 1998, 42:1033-1037.
34. Honkavaara P, Pyykkö I Effects of atropine and scopolamine on bradycardia and emetic symptoms in otoplasty. Laryngoscope. 1999, 109:108-112.
35. Honkavaara P, Pyykkö I, Rutanen EM Increased incidence of retching and vomiting during periovulatory phase after middle ear surgery. Can J Anaesth. 1996, 43:1108-1114.
36. Tolksdorf W, Meisel R, Müller P, Bender HJ Transdermal scopolamine (TTS-scopolamine) for the prevention of postoperative nausea and vomiting [in German]. Anaesthesist. 1985, 34:656-662.
37. Tolksdorf W, Baumann S, Heine C, Hettenbach A Effects and side effects of transdermal scopolamine for premedication in general anesthesia in elderly patients [in German]. Anasth Intensivther Notfallmed. 1986, 21:301-306.
38. Uppington J, Dunnet J, Blogg CE Transdermal hyoscine and postoperative nausea and vomiting. Anaesthesia. 1986, 41:16-20.
39. Tigerstedt I, Salmela L, Aromaa U Double-blind comparison of transdermal scopolamine, droperidol and placebo against postoperative nausea and vomiting. Acta Anaesthesiol Scand. 1988, 32:454-457.
40. Jespersen TW, Koch J, Anker-Moller E, et al. Transdermal scopolamine to prevent postoperative nausea and vomiting after uterine curettage and termination of pregnancy. A doubleblind clinically controlled study with placebo [in Danish]. Ugeskr Laeger. 1989, 151:1246-1248.
41. Kotelko DM, Rottman RL, Wright WC, et al. Transdermal scopolamine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology. 1989, 71:675-678.
42. Loper KA, Ready LB, Dorman BH Prophylactic transdermal scopolamine patches reduce nausea in postoperative patients receiving epidural morphine. Anesth Analg. 1989, 68:144-146.
43. Wilkinson AR, Frampton CM, Glover PW, Davis FM Preoperative transdermal hyoscine for the prevention of postoperative nausea and vomiting. Anaesth Intens Care. 1989, 17:285-289.
44. Bailey PL, Streisand JB, Pace NL, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology. 1990, 72:977-980.
45. Koski EM, Mattila MA, Knapik D, et al. Double blind comparison of transdermal hyoscine and placebo for the prevention of postoperative nausea. BrJ Anaesth. 1990, 64:16-20.
46. Santamaria LB, Fodale V, Mandolfino T, et al. Transdermal scopolamine reduces nausea, vomiting and sialorrhea in the postoperative period in teeth and mouth surgery [in Italian]. Minerva Anestesiol. 1991, 57:686-687.
47. Stromberg BV, Reines DH, Ackerly J Transderm scopolamine for the control of perioperative nausea. Am Surg. 1991, 57:712-715.
48. Bosek V, Downs JB Nausea and vomiting after alfentanil anesthesia: Effect of transdermal scopolamine. Anesthesiol Rev. 1992, 19:19-22.
49. Semple P, Madej TH, Wheatley RG, et al. Transdermal hyoscine with patient-controlled analgesia. Anaesthesia. 1992, 47:399-401.
50. Honkavaara P, Saarnivaara L, Klemola UM Prevention of nausea and vomiting with transdermal hyoscine in adults after middle ear surgery during general anaesthesia. Br J Anaesth. 1994, 73:763-766.
51. Reinhart DJ, Klein KW, Schroff E Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: A doubleblind, randomized study. Anesth Analg. 1994, 79:281-284.
52. Sohi HS, Heipel J, Inman KJ, et al. Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy. Can J Surg. 1994, 37:307-312.
53. Eberhart LH, Holzrichter P, Roscher R Transdermal scopolamine for prevention of postoperative nausea and vomiting. No clinically relevant result in spite of reduced postoperative vomiting in general surgical and gynecologic patients [in German]. Anaesthesist. 1996, 45:259-267.
54. Honkavaara P Effect of transdermal hyoscine on nausea and vomiting during and after middle ear surgery under local anaesthesia. BrJ Anaesth. 1996, 76:49-53.
55. Jones S, Strobl R, Crosby D, et al. The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron. AANA J. 2006, 74:127-132.
56. Harnett MJ, O'Rourke N, Walsh M, et al. Transdermal scopolamine for prevention of intrathecal morphineinduced nausea and vomiting after cesarean delivery. Anesth Analg. 2007, 105:764-769.
57. Einarsson JI, Audbergsson BO, Thorsteinsson A Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial. J Minim Invasive Gynecol. 2008, 15:26-31.
58. Gan TJ, Sinha AC, Kovac AL, et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg. 2009, 108:1498-1504. TDS Study Group.
59. Lazar RH, Alperin KM, Hughes GB, et al. Efficacy of transdermal scopolamine as an antinauseant for stapes operation. Surg Forum. 1984, 35:558-561.
60. Lee HK, Lee JH, Chon SS, et al. The effect of transdermal scopolamine plus intravenous dexamethasone for the prevention of postoperative nausea and vomiting in patients with epidural PCA after major orthopedic surgery. Korean J Anesthesiol. 2010, 58:50-55.
61. Gan TJ, Kovac LA, Sinha AC, et al. Comparison of transdermal scopolamine patch and ondansetron to ondansetron for prevention of PONV. Anesthesiology 2007, 107:A1020.
62. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004, 350:2441-2451. IMPACT Investigators.
63. Apfel CC, Cakmakkaya OS, Frings G, et al. Droperidol has comparable clinical efficacy against both nausea and vomiting. Br J Anaesth. 2009, 103:359-363.
64. Jokela RM, Cakmakkaya OS, Danzeisen O, et al. Ondansetron has similar clinical efficacy against both nausea and vomiting. Anaesthesia. 2009, 64:147-151.
65. Firth AY, Walker K Visual side-effects from transdermal scopolamine (hyoscine). Dev Med Child Neurol. 2006, 48:137-138.
66. Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. Anesthesiology. 1999, 91:693-700.
67. Gan TJ, Meyer TA, Apfel CC, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2007, 105:1615-1628. Society for Ambulatory Anesthesia.
68. Kovac AL, O'Connor TA, Pearman MH, et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: A randomized, doubleblind, placebo-controlled multicenter trial. J Clin Anesth. 1999, 11:453-459.